Chen Min

Chen Min has a long and varied work experience. Chen began their career in 1987 as a Physician at the Fujian Hepatic Research Institute and Infectious Disease Hospital, where they worked closely with patients suffering from infectious diseases. In 1998, they moved to the United States and took on a role as a Research Associate at the University of Pennsylvania. Chen then moved to Xenogen Corporation in 2003, where they held the role of Senior Research Scientist and was responsible for drug metabolism transgenic animal model development and characterization, oncology research animal model development, and fluorescence and bio-luminescence in vivo image for drug efficacy screening. In 2007, they joined Novartis as a Scientist, where they were responsible for oncology pharmacology target validation and actively participated in several small molecule drug development projects and the Antibody Drug Conjugated immuno-therapy group. Finally, in 2014, they joined Virovek, Inc. as President & CFO and Vice President of Human Resources.

Chen Min began their educational journey in 1982 when they earned their MD from Fujian Medical University in the field of Infectious Disease. Chen then went on to pursue a Post Doc Fellow at the Kansas University Medical Center from 1993 to 1996, focusing their studies on Molecular Biology & Biochemistry.